imipramine has been researched along with Constriction, Pathological in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yasuda, S | 1 |
| Yoshida, M | 1 |
| Yamagata, H | 1 |
| Iwanaga, Y | 1 |
| Suenaga, H | 1 |
| Ishikawa, K | 1 |
| Nakano, M | 1 |
| Okuyama, S | 1 |
| Furukawa, Y | 1 |
| Furukawa, S | 1 |
| Ishikawa, T | 1 |
1 other study available for imipramine and Constriction, Pathological
| Article | Year |
|---|---|
Imipramine ameliorates pain-related negative emotion via induction of brain-derived neurotrophic factor.
Topics: 5,7-Dihydroxytryptamine; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Chronic | 2014 |